The impact of hepatitis C burden: an evidence‐based approach

@article{Younossi2014TheIO,
  title={The impact of hepatitis C burden: an evidence‐based approach},
  author={Z. Younossi and F. Kanwal and S. Saab and K. Brown and H. El-Serag and W. Kim and A. Ahmed and M. Kugelmas and S. Gordon},
  journal={Alimentary Pharmacology & Therapeutics},
  year={2014},
  volume={39}
}
  • Z. Younossi, F. Kanwal, +6 authors S. Gordon
  • Published 2014
  • Medicine
  • Alimentary Pharmacology & Therapeutics
  • Infection with the hepatitis C virus (HCV) has been considered a major cause of mortality, morbidity and resource utilisation in the US. In addition, HCV is the main cause of hepatocellular cancer (HCC) in the US. Recent developments in the diagnosis and treatment of HCV, including new recommendations pertaining to screening for HCV by the Centers for Disease Control and Prevention and newer treatment regimens with high efficacy, short duration and the potential for interferon‐free therapies… CONTINUE READING
    107 Citations
    The impact of the new antiviral regimens on patient reported outcomes and health economics of patients with chronic hepatitis C.
    • Z. Younossi, L. Henry
    • Medicine
    • Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
    • 2014
    • 59
    Interferon‐free therapy in hepatitis C virus mixed cryoglobulinaemia: a prospective, controlled, clinical and quality of life analysis
    • 8
    Long-Term Treatment Outcomes of Patients Infected With Hepatitis C Virus: A Systematic Review and Meta-analysis of the Survival Benefit of Achieving a Sustained Virological Response
    • 194
    • PDF

    References

    SHOWING 1-10 OF 124 REFERENCES
    Natural history of acute and chronic hepatitis C.
    • 207
    A sustained virologic response reduces risk of all-cause mortality in patients with hepatitis C.
    • 441
    • PDF
    Economic burden of hepatitis C‐associated diseases in the United States
    • 69
    • PDF
    Interferon-Free Hepatitis C Therapy
    • 21
    Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection.
    • 350
    • PDF